
Charvi Kalal
PharmD
Charvi Kalal is a Pharm.D intern and aspiring medical writer with hands-on experience in medical writing, clinical research, pharmacovigilance, and clinical pharmacy. She has experience in medical content writing through CliMed, along with exposure to ADR monitoring, prescription analysis, patient counselling, literature review, and research documentation. Her research focuses on ADR monitoring and reporting in breast cancer patients receiving targeted therapy. With certifications in GCP, biomedical research, scientific writing, and clinical research, she is passionate about transforming scientific evidence into accurate, engaging, and accessible healthcare content.
About Charvi
Charvi Kalal (PharmD) is a writer at Pharmacally, with 44 published articles, each checked against primary sources by our editorial team.
Articles by Charvi Kalal
Clinical TrialsCellectar’s Iopofosine I 131 Shows 87.5% Response Rate in WM
Clinical TrialsTAK-881 Meets Primary PK Endpoint, Reducing Infusion Burden in PID
Clinical TrialsSyndax Ends Axatilimab Development in IPF After Phase 2 Failure
Clinical TrialsAcoramidis Shows 34% Lower Hazard of Composite Clinical Worsening Than Tafamidis in Real-World ATTR-CM Study
Health TidingsGlaukos Reports 3.6 mmHg Added IOP Reduction With iDose TR During Cataract Surgery
Clinical TrialsForte-Acquired FB102 Delivers Positive Phase 2 Results in Celiac Disease
Clinical TrialsPulseSight Reports Favorable Safety and Early Efficacy Signals for PST-611 in Geographic Atrophy
Clinical TrialsKairos Reports Significant PFS Improvement With ENV-105 in mCRPC
Health TidingsSerum Institute of India’s HPV Vaccine CERVAVAC Receives WHO Prequalification
A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala